Cisatracurium is a non-depolarizing neuromuscular blocking agent belonging to the benzylisoquinolinium class, primarily used in clinical settings to facilitate tracheal intubation and provide skeletal… Read more































Cisatracurium is a non-depolarizing neuromuscular blocking agent belonging to the benzylisoquinolinium class, primarily used in clinical settings to facilitate tracheal intubation and provide skeletal muscle relaxation during anesthesia. This category provides comprehensive analytical tools, including reference standards of the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope labelled compounds. These high-quality standards are essential for pharmaceutical laboratories engaged in impurity profiling, analytical method validation, and rigorous quality control. By using these well-characterized substances, researchers can accurately monitor degradation pathways such as ester hydrolysis and Hofmann elimination to ensure the safety and potency of the drug product. These reference materials support compliance with regulatory standards, facilitating precise identification and quantification of impurities during stability testing and routine batch analysis to maintain high pharmaceutical manufacturing integrity.